Literature DB >> 25219857

Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086.

Edna P Nyangale1, Sean Farmer2, David Keller2, David Chernoff3, Glenn R Gibson4.   

Abstract

In advancing age, gut populations of beneficial microbes, notably Bifidobacterium spp., show a marked decline. This contributes to an environment less capable of maintaining homoeostasis. This in vitro investigation studied the possible synergistic effects of probiotic supplementation in modulating the gut microbiota enabling prebiotic therapy to in elderly persons. Single stage batch culture anaerobic fermenters were used and inoculated with fecal microbiota obtained from volunteers after taking a 28 day treatment of Bacillus coagulans GBI-30, 6086 (GanedenBC30 (BC30)) or a placebo. The response to prebiotic supplements fructooligosaccharides (FOS) and galactooligosaccharides (GOS) in the fermenters was assessed. Bacterial enumeration was carried out using fluorescent in situ hybridisation and organic acids measured by gas chromatography. Baseline populations of Faecalibacterium prausnitzii, Clostridium lituseburense and Bacillus spp. were significantly higher in those having consumed BC30 compared to the placebo. Both prebiotics increased populations of several purportedly beneficial bacterial groups in both sets of volunteers. Samples from volunteers having ingested the BC30 also increased populations of C. lituseburense, Eubacterium rectale and F. prausnitzii more so than in persons who had consumed the placebo, this also resulted in significantly higher concentrations of butyrate, acetate and propionate. This shows that consumption of BC30 and subsequent use of prebiotics resulted in elevated populations of beneficial genres of bacteria as well as organic acid production.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacillus coagulans; Batch culture fermentation; Fructooligosaccharides; Galactooligosaccharides; Probiotic; Synbiotic

Mesh:

Substances:

Year:  2014        PMID: 25219857     DOI: 10.1016/j.anaerobe.2014.09.002

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  16 in total

1.  Effect of Probiotic Bacillus Coagulans and Lactobacillus Plantarum on Alleviation of Mercury Toxicity in Rat.

Authors:  Majid Majlesi; Seyed Shahram Shekarforoush; Hamid Reza Ghaisari; Saeid Nazifi; Javad Sajedianfard; Mohammad Hadi Eskandari
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

2.  Oral Administration of a Select Mixture of Bacillus Probiotics Affects the Gut Microbiota and Goblet Cell Function following Escherichia coli Challenge in Newly Weaned Pigs of Genotype MUC4 That Are Supposed To Be Enterotoxigenic E. coli F4ab/ac Receptor Negative.

Authors:  Wei Zhang; Yao-Hong Zhu; Dong Zhou; Qiong Wu; Dan Song; Johan Dicksved; Jiu-Feng Wang
Journal:  Appl Environ Microbiol       Date:  2017-01-17       Impact factor: 4.792

3.  The investigation of bioremediation potential of Bacillus subtilis and B. thuringiensis isolates under controlled conditions in freshwater.

Authors:  Ayşe Kalaycı Kara; Özden Fakıoğlu; Recep Kotan; Muhammed Atamanalp; Gonca Alak
Journal:  Arch Microbiol       Date:  2021-02-17       Impact factor: 2.552

Review 4.  The gut microbiome as a modulator of healthy ageing.

Authors:  Tarini Shankar Ghosh; Fergus Shanahan; Paul W O'Toole
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-04-25       Impact factor: 73.082

Review 5.  May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry.

Authors:  Eoin Sherwin; Kiran V Sandhu; Timothy G Dinan; John F Cryan
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

Review 6.  Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives.

Authors:  Fouad M F Elshaghabee; Namita Rokana; Rohini D Gulhane; Chetan Sharma; Harsh Panwar
Journal:  Front Microbiol       Date:  2017-08-10       Impact factor: 5.640

7.  Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro.

Authors:  Gitte S Jensen; Howard A Cash; Sean Farmer; David Keller
Journal:  J Inflamm Res       Date:  2017-08-07

8.  The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments.

Authors:  Yong-Ku Kim; Cheolmin Shin
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery.

Authors:  Ralf Jäger; Kevin A Shields; Ryan P Lowery; Eduardo O De Souza; Jeremy M Partl; Chase Hollmer; Martin Purpura; Jacob M Wilson
Journal:  PeerJ       Date:  2016-07-21       Impact factor: 2.984

Review 10.  Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization.

Authors:  Ralf Jäger; Martin Purpura; Sean Farmer; Howard A Cash; David Keller
Journal:  Probiotics Antimicrob Proteins       Date:  2018-12       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.